| Market Cap | 139.67B | P/E | 17.33 | EPS this Y | -0.50% | Ern Qtrly Grth | 4.00% |
| Income | 8B | Forward P/E | 11.83 | EPS next Y | 7.30% | 50D Avg Chg | 12.00% |
| Sales | 298.77B | PEG | 1.91 | EPS past 5Y | 10.62% | 200D Avg Chg | 7.00% |
| Dividend | 2.00% | Price/Book | 1.86 | EPS next 5Y | 5.74% | 52W High Chg | -4.00% |
| Recommedations | 2.20 | Quick Ratio | 0.54 | Shares Outstanding | 1.31B | 52W Low Chg | 30.00% |
| Insider Own | 0.34% | ROA | 3.86% | Shares Float | 1.31B | Beta | 0.77 |
| Inst Own | 80.20% | ROE | 10.99% | Shares Shorted/Prior | 14.64M/13.95M | Price | 106.39 |
| Gross Margin | 17.35% | Profit Margin | 2.68% | Avg. Volume | 4,947,175 | Target Price | 117.39 |
| Oper. Margin | 4.77% | Earnings Date | Aug 3 | Volume | 4,982,319 | Change | 2.05% |
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
| Loop Capital | Buy | Jun 17, 22 |
| Bernstein | Market Perform | May 27, 22 |
| Deutsche Bank | Hold | May 5, 22 |
| Morgan Stanley | Overweight | May 5, 22 |
| Deutsche Bank | Hold | Mar 29, 22 |
| Raymond James | Outperform | Feb 14, 22 |
| Tigress Financial | Buy | Dec 23, 21 |
| Mizuho | Buy | Dec 20, 21 |
| Goldman Sachs | Buy | Dec 14, 21 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Lotvin Alan | EVP&President-Pharma.. EVP&President-PharmacyServices | Aug 03 | Option | 58.25 | 143,440 | 8,355,380 | 131,724 | 08/05/22 |
| Lotvin Alan | EVP&President-Pharma.. EVP&President-PharmacyServices | Aug 03 | Sell | 100 | 143,440 | 14,344,000 | 109,183 | 08/05/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Aug 03 | Option | 52.37 | 9,546 | 499,924 | 41,696 | 08/05/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Aug 03 | Sell | 100 | 9,546 | 954,600 | 32,150 | 08/05/22 |
| Moriarty Thomas M | EVP & General Counse.. EVP & General Counsel | Jun 28 | Option | 62.28 | 138,654 | 8,635,371 | 665,146 | 06/30/22 |
| Moriarty Thomas M | EVP & General Counse.. EVP & General Counsel | Jun 28 | Sell | 95 | 138,654 | 13,172,130 | 626,273 | 06/30/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Apr 08 | Option | 62.26 | 13,824 | 860,682 | 50,686 | 04/12/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Apr 08 | Sell | 105 | 16,954 | 1,780,170 | 43,453 | 04/12/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Apr 04 | Option | 56.27 | 43,327 | 2,438,010 | 77,289 | 04/06/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Apr 04 | Sell | 100.1 | 61,300 | 6,136,130 | 32,150 | 04/06/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 30 | Option | 102.26 | 5,346 | 546,682 | 64,417 | 03/31/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 30 | Sell | 104.7 | 5,346 | 559,726 | 59,071 | 03/31/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 17 | Option | 104.82 | 2,935 | 307,647 | 62,006 | 03/18/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 17 | Sell | 106.65 | 4,624 | 493,150 | 59,071 | 03/18/22 |
| LUDWIG EDWARD J | Director Director | Feb 10 | Buy | 105.9044 | 1,000 | 105,904 | 18,334 | 02/11/22 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Feb 03 | Sell | 110 | 47,937 | 5,273,070 | 138,246 | 02/04/22 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Feb 03 | Option | 102.26 | 47,937 | 4,902,038 | 186,183 | 02/04/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Jan 28 | Option | 102.26 | 6,059 | 619,593 | 23,556 | 02/01/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Jan 28 | Sell | 109 | 6,059 | 660,431 | 17,497 | 02/01/22 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Jan 27 | Option | 102.26 | 68,482 | 7,002,969 | 175,597 | 01/28/22 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Jan 27 | Sell | 107.5 | 68,482 | 7,361,815 | 107,115 | 01/28/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Apr 01 | Option | 74.29 | 5,350 | 397,452 | 12,594 | 04/01/21 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Apr 01 | Sell | 76 | 5,350 | 406,600 | 7,244 | 04/01/21 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Mar 29 | Sell | 74.49 | 73,433 | 5,470,024 | 664 | 03/29/21 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Mar 29 | Option | 74.29 | 73,433 | 5,455,338 | 74,097 | 03/29/21 |
| MERLO LARRY J | Director Director | Mar 29 | Option | 74.29 | 271,347 | 20,158,369 | 794,676 | 03/29/21 |
| MERLO LARRY J | Director Director | Mar 29 | Sell | 74.73 | 270,650 | 20,225,674 | 524,026 | 03/29/21 |
| Bisaccia Lisa | EVP and Chief HR Off.. EVP and Chief HR Officer | Jan 13 | Option | 74.29 | 25,177 | 1,870,399 | 71,765 | 01/13/21 |
| Bisaccia Lisa | EVP and Chief HR Off.. EVP and Chief HR Officer | Jan 13 | Sell | 77 | 25,177 | 1,938,629 | 46,588 | 01/13/21 |
| Lotvin Alan | EVP and President-CV.. EVP and President-CVS Caremark | Jan 12 | Option | 64.24 | 25,836 | 1,659,705 | 34,205 | 01/12/21 |
| Lotvin Alan | EVP and President-CV.. EVP and President-CVS Caremark | Jan 12 | Sell | 75 | 25,836 | 1,937,700 | 8,369 | 01/12/21 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Jan 12 | Option | 74.29 | 54,550 | 4,052,520 | 100,558 | 01/12/21 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Jan 12 | Sell | 75 | 58,896 | 4,417,200 | 46,008 | 01/12/21 |